One price for everyone. All-inclusive.
A single price, the same for every company, with no add-ons and no hidden costs. You get all of Redmontis on an annual subscription, payable quarterly.
That is four quarterly instalments of 4 500 €, with no surcharge.
Every feature, every user and onboarding support are included.
Request a demoAnnual amount excluding tax, per company, payable in four equal quarterly instalments with no surcharge. The price depends neither on the number of users, nor on your company's capital, nor on the funding it raises (article 4 of our general terms, in French).
All of Redmontis, for everyone.
No setup fee, no per-user cost, no feature reserved for a higher plan.
- Runway, cash and burn in real time
- Biotech-native FP&A modeling
- Clinical milestones tied to cash
- Unlimited compared scenarios
- One-click board and investor reporting
- CIR calculation and funding tracking
- Alerts on critical funding points
- Onboarding support
- Unlimited users
- Updates included
- French or English interface
- Accounting reconciliation and connector to your tool
Three commitments, written into the contract.
These are not sales arguments: they are articles of our general terms, binding and dated.
90 days to judge. One quarter, at most.
Within 90 days of go-live, you write to us that Redmontis has no place in your decision-making. You have nothing to justify, and we cannot argue with your judgement. The contract ends at the close of the current quarter: no further instalment is due. Your commitment stops there, at one quarter.
+ 20 % cap. Your price stays predictable.
Your price cannot increase by more than 20 % from one renewal to the next. A funding round mid-period changes nothing: the price does not depend on your funding.
One instalment. Your exposure is capped.
Should you cease trading, or enter an amicable or insolvency proceeding, we waive all instalments not yet due. Only the current quarter remains payable.
Articles 7, 8 and 9 of our general terms of sale and subscription, version of 23 October 2026. The French version of the general terms is the only binding one.
18 000 €, compared to the real alternatives.
Price isn't judged on its own, but against what an executive pays today to run their finances, and against the cost of a decision made too late.
- Cheaper than every real alternative, starting with the one you are already using
- Marginal next to a single bad runway call, which runs into the hundreds of thousands of euros
- Scenarios in 3 hours, instead of 4 to 6 weeks of manual rebuilding
Sources: outsourced CFO, Pilot (Fractional CFO Cost Guide, 2026); horizontal FP&A tools, Vendr and Limelight (2026); impact of a single decision, 2 to 3 months of burn; market data, Panorama France HealthTech 2026. 3-hour turnaround: feedback from CEO and CFO users.
What people ask before signing.
How is the subscription paid?
In four equal quarterly instalments, with no surcharge, on a twelve-month commitment. Paying the year in advance is possible, with a discount set out in your contract.
Are there any setup fees?
No. Initial configuration and migration of your existing model are included in the price, within the limit set out in your contract.
What if the tool does not find its place with us?
You write to us within 90 days of go-live, with nothing to justify. The contract ends at the close of the current quarter: that quarter remains payable, no other instalment does. If you had paid the year in advance, the quarters not started are refunded within 30 days. On monthly payment, the contract ends at the close of the current month.
What if our company ceases trading?
We waive all instalments not yet due. Only the current quarter remains payable.
Judge it on your own numbers.
A 30-minute demo is enough to see whether the time reclaimed justifies the subscription. Your call, no commitment.
Request a demoPublic price list in force as of 23 October 2026. The applicable general terms of sale and subscription are those of the version of 23 October 2026, whose French text is the only binding one.